ArticleDiabetes, obesity & metabolism2021

Gastrointestinal adverse events with insulin glargine/lixisenatide fixed-ratio combination versus glucagon-like peptide-1 receptor agonists in people with type 2 diabetes mellitus: A network meta-analysis.

Christopher K Rayner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.